article thumbnail

UK scientists prepare for Nipah virus clinical trial

Drug Discovery World

The University of Oxford has revealed that researchers are currently in the advanced stages of preparing for a clinical trial of a Nipah vaccine using the ChAdOx1 vector. Seasonal outbreaks have occurred annually in Bangladesh since 2001.

article thumbnail

The Moving Regulatory Landscape for Gene Therapy Trials in EU: Part 2

thought leadership

Change in the Submission of the Summary Notification Information Format The Summary Notification Information Format Form As of January 31, 2023, Sponsors are required to submit a Clinical Trial Application (CTA) in the EU through the Clinical Trial Information System (CTIS).

Trials 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Report: huge inequalities in access to myeloma clinical trials in Europe 

Drug Discovery World

Myeloma Patients Europe (MPE) has launched an advocacy report on addressing access barriers to myeloma clinical trials in Central and Eastern Europe (CEE). . The MPE report presents clinical trial analytics, looking at the number of clinical trials held in CEE countries between 1 January 2001 and 28 September 2020.

article thumbnail

News from AACR 2024: Sunday’s highlights

Drug Discovery World

Ichnos Glenmark Innovation Ichnos Glenmark Innovation (IGI), an alliance between Ichnos Sciences and Glenmark Pharmaceuticals, shared pre-clinical data for its oncology asset ISB 2001, which is currently being tested in a Phase I clinical trial in relapsed/refractory multiple myeloma (r/r MM).

DNA 130
article thumbnail

The evolution and future of gene therapy

Drug Discovery World

Dr Samulski has advanced therapeutics into human clinical trials for haemophilia, Duchenne muscular dystrophy, giant axonal neuropathy, Pompe disease and heart failure. He co-founded AskBio in 2001 and in October 2020, Bayer acquired AskBio for $4 billion. He holds more than 200 patents related to AAV technology.

Therapies 130
article thumbnail

Podcast: The evolution and future of gene therapy

Drug Discovery World

Dr Samulski has advanced therapeutics into human clinical trials for haemophilia, Duchenne muscular dystrophy, giant axonal neuropathy, Pompe disease and heart failure. He co-founded AskBio in 2001 and in October 2020, Bayer acquired AskBio for $4 billion. He holds more than 200 patents related to AAV technology.

Therapies 130
article thumbnail

New and Emerging CMS Policies: Medicaid’s New Clinical Trial Policy

Advarra

The Centers for Medicare & Medicaid Services (CMS) released a letter outlining routine costs in clinical trials for patients eligible for Medicaid in April 2022. However, a year has passed with no further updates on this letter or Medicaid beneficiaries enrolling in clinical trials. outlining routine costs in clinical trials.